Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Orchestra BioMed Holdings Inc shares valued at $149,201 were purchased by RTW INVESTMENTS, LP on Apr 30 ’25. At $2.99 per share, RTW INVESTMENTS, LP acquired 49,900 shares. The insider’s holdings grew to 8,306,063 shares worth approximately $24.84 million following the completion of this transaction.
Also, RTW INVESTMENTS, LP purchased 50,000 shares, netting a total of over 126,500 in proceeds. Following the buying of shares at $2.53 each, the insider now holds 8,256,163 shares.
Before that, Hochman David P had added 4,000 shares to its account. In a trade valued at $18,640, the insider bought Orchestra BioMed Holdings Inc shares for $4.66 each. Upon closing the transaction, the insider’s holdings increased to 4,000 shares, worth approximately $1.73 million.
As published in their initiating research note from BTIG Research on March 20, 2025, Orchestra BioMed Holdings Inc [OBIO] has been a Buy and the price target has been revised to $12. Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in early January. As of August 22, 2024, H.C. Wainwright has initiated its “Buy” rating for OBIO. Earlier on July 25, 2024, B. Riley Securities initiated its rating. Their recommendation was “a Buy” for OBIO stock.
Analyzing OBIO Stock Performance
On last trading session,, Orchestra BioMed Holdings Inc [NASDAQ: OBIO] plunged -11.01% to $2.99. During the last five days, there has been a drop of approximately -5.68%. Over the course of the year, Orchestra BioMed Holdings Inc shares have dropped approximately -25.25%. Shares of the company reached a 52-week high of $6.30 on 01/02/25 and a 52-week low of $2.37 on 05/07/25.
Support And Resistance Levels for Orchestra BioMed Holdings Inc (OBIO)
According to the 24-hour chart, there is a support level at 2.79, which, if violated, would cause prices to drop to 2.58. In the upper region, resistance lies at 3.32. The next price resistance is at 3.64. RSI (Relative Strength Index) is 47.21 on the 14-day chart, showing neutral technical sentiment.
Which companies own the most shares of Orchestra BioMed Holdings Inc (OBIO)?
In terms of Orchestra BioMed Holdings Inc share price expectations, FactSet research, analysts set an average price target of 12 in the next 12 months, up nearly 257.14% from the previous closing price of $3.36. Analysts anticipate Orchestra BioMed Holdings Inc stock to reach 12 by 2025, with the lowest price target being 12. On January 19, 2024, Jefferies assigned a price target of “a Buy” to the stock and initiated coverage with a $14.
